Literature DB >> 23229452

New ACR guidelines for gout management hold some surprises.

Thomas Bardin1, Pascal Richette.   

Abstract

Despite exciting progress in the understanding and treatment of gout, management of this condition remains suboptimal. In the face of this inadequacy, new guidelines provide recommendations both for therapeutic approaches to hyperuricaemia and for the management and anti-inflammatory prophylaxis of acute gouty arthritis.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23229452     DOI： 10.1038/nrrheum.2012.216

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  9 in total

1.  British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

Authors:  Kelsey M Jordan; J Stewart Cameron; Michael Snaith; Weiya Zhang; Michael Doherty; Jonathan Seckl; Aroon Hingorani; Richard Jaques; George Nuki
Journal:  Rheumatology (Oxford)       Date:  2007-05-23       Impact factor: 7.580

2.  High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.

Authors:  Robert A Terkeltaub; Daniel E Furst; Katherine Bennett; Karin A Kook; R S Crockett; Matthew W Davis
Journal:  Arthritis Rheum       Date:  2010-04

3.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

4.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

5.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.

Authors:  Yanyan Zhu; Bhavik J Pandya; Hyon K Choi
Journal:  Arthritis Rheum       Date:  2011-10

Review 6.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

7.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 8.  Gout: why is this curable disease so seldom cured?

Authors:  Michael Doherty; Tim L Jansen; George Nuki; Eliseo Pascual; Fernando Perez-Ruiz; Leonardo Punzi; Alexander K So; Thomas Bardin
Journal:  Ann Rheum Dis       Date:  2012-08-03       Impact factor: 19.103

Review 9.  Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Authors:  Ratchadaporn Somkrua; Elizabeth E Eickman; Surasak Saokaew; Manupat Lohitnavy; Nathorn Chaiyakunapruk
Journal:  BMC Med Genet       Date:  2011-09-09       Impact factor: 2.103
  9 in total
  2 in total

1.  Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements.

Authors:  Qianrui Li; Xiaodan Li; Jing Wang; Hongdie Liu; Joey Sum-Wing Kwong; Hao Chen; Ling Li; Sheng-Chia Chung; Anoop Shah; Yaolong Chen; Zhenmei An; Xin Sun; Harry Hemingway; Haoming Tian; Sheyu Li
Journal:  BMJ Open       Date:  2019-08-24       Impact factor: 2.692

2.  Efficacy and safety of febuxostat in elderly female patients.

Authors:  Tomohiro Mizuno; Takahiro Hayashi; Sayo Hikosaka; Yuka Shimabukuro; Maho Murase; Kazuo Takahashi; Hiroki Hayashi; Yukio Yuzawa; Tadashi Nagamatsu; Shigeki Yamada
Journal:  Clin Interv Aging       Date:  2014-09-04       Impact factor: 4.458
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.